Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus

被引:43
作者
Maslo, C
Peraldi, MN
Desenclos, JC
Mougenot, B
CywinerGolenzer, C
Chatelet, FP
Jacomet, C
Rondeau, E
Rozenbaum, W
Sraer, JD
机构
[1] HOP ROTHSCHILD, LAB ANATOMOPATHOL, F-75012 PARIS, FRANCE
[2] HOP TENON, SERV NEPHROL, F-75970 PARIS, FRANCE
[3] HOP TENON, LAB ANATOMOPATHOL, F-75970 PARIS, FRANCE
[4] RESEAU NATL SANTE PUBL, ST MAURICE, FRANCE
关键词
D O I
10.1093/clinids/24.3.350
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thrombotic microangiopathy (TMA) fan occur during the course of human immunodeficiency virus (HIV) infection. Clinical and pathological data for 29 patients with TM and HIV infection were recorded. In a retrospective case-control study, we analyzed the link between opportunistic infections or drug therapies and TMA. Twenty-five patients (mean CD4(+) cell count +/- SD, 71.9 +/- 18.3/mm(3)) had renal impairment, and four had neurological dysfunction. In one-half the cases, the disease was progressive with isolated fragmentation anemia appearing several months before the clinical symptoms. The diagnosis of TMA was confirmed by histological examination of kidney biopsy specimens (18 cases). Endothelial cytomegalovirus (CMV) inclusions were associated with TMA in nine of 18 eases, whereas histological examination did not detect CMV in any control specimens (P < .001). The case-control study demonstrated a link between TMA and clinical CMV infection (odds ratio, 3.9; 95% confidence interval, 1.1-14). We conclude that TMA is a late complication of HIV infection and can be associated with systemic CMV infection in this setting.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 32 条
[1]  
BATTEGAY EJ, 1988, CLIN NEPHROL, V30, P239
[2]  
BOYCE NW, 1988, TRANSPLANTATION, V45, P706
[3]   INCIDENCE AND NATURAL-HISTORY OF CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE [J].
GALLANT, JE ;
MOORE, RD ;
RICHMAN, DD ;
KERULY, J ;
CHAISSON, RE ;
BARTLETT, J ;
MCAVINUE, S ;
BRYSON, Y ;
COHEN, H ;
FISCHL, M ;
BOLIN, T ;
KESSLER, H ;
BURROUGH, Y ;
MILDVAN, D ;
FOX, A ;
RICHMAN, D ;
FREEMAN, B ;
SIMON, G ;
GRABOWY, KW ;
CHERNOFF, D ;
DUFF, P ;
THOMPSON, S ;
BARRETT, K ;
AWE, R ;
CHAPMAN, R ;
LEONARD, S ;
BAINES, L ;
TURNER, P ;
HAWKINS, M ;
MURRAY, H ;
BOWERS, J ;
LANE, C ;
TILSON, H ;
ANDREWS, E ;
SMILEY, L .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) :1223-1227
[4]   CYTOMEGALOVIRUS VASCULITIS [J].
GOLDEN, MP ;
HAMMER, SM ;
WANKE, CA ;
ALBRECHT, MA .
MEDICINE, 1994, 73 (05) :246-255
[5]   GASTROINTESTINAL CYTOMEGALOVIRUS DISEASE [J].
GOODGAME, RW .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (09) :924-935
[6]   FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1990, 39 (06) :877-916
[7]   ULTRASTRUCTURAL ANALYSIS OF CIRCULATING CYTOMEGALIC CELLS IN PATIENTS WITH ACTIVE CYTOMEGALOVIRUS-INFECTION - EVIDENCE FOR VIRUS PRODUCTION AND ENDOTHELIAL ORIGIN [J].
GREFTE, A ;
BLOM, N ;
VANDERGIESSEN, M ;
VANSON, W ;
THE, TH .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (05) :1110-1118
[8]   CIRCULATING CYTOMEGALOVIRUS (CMV)-INFECTED ENDOTHELIAL-CELLS IN PATIENTS WITH AN ACTIVE CMV INFECTION [J].
GREFTE, A ;
VANDERGIESSEN, M ;
VANSON, W ;
THE, TH .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (02) :270-277
[9]   SYNERGISTIC INFECTION WITH MURINE CYTOMEGALOVIRUS AND CANDIDA-ALBICANS IN MICE [J].
HAMILTON, JR ;
OVERALL, JC ;
GLASGOW, LA .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (06) :918-924
[10]   RECOMBINANT INTERFERON-ALPHA AND HEMOLYTIC-UREMIC SYNDROME - CAUSE OR COINCIDENCE [J].
HARVEY, M ;
ROSENFELD, D ;
DAVIES, D ;
HALL, BM .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (02) :152-153